United Kingdom

People: Aquestive Therapeutics Inc (AQST.OQ)

AQST.OQ on NASDAQ Stock Exchange Global Market

15 Jul 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Barber, Daniel 

Mr. Daniel Barber is Chief Operating Officer, Senior Vice President of the Company. he was Senior Vice President, Chief Strategy and Development Officer of the company. He joined our team in July 2007 and has led our Strategy and Development functions since April 2014. Prior to joining our team, Mr. Barber held various positions with Quest Diagnostics in its corporate planning and international divisions. In 2010, Mr. Barber had executive oversight of our launch activities for our first two FDA approved products. Beginning in 2013, Mr. Barber helped lead our effort to develop an internal pipeline of proprietary assets. Since that time, he has had executive responsibility for our pipeline and partnership activities. Mr. Barber received his BA degree from State University of New York at Geneseo and an MBA from Seton Hall University.

Basic Compensation

Total Annual Compensation, USD 501,390
Restricted Stock Award, USD 378,652
Long-Term Incentive Plans, USD --
All Other, USD 18,858
Fiscal Year Total, USD 898,900

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --